Retraction Notice to: FoxP3 Acts as a Cotranscription Factor with STAT3 in Tumor-Induced Regulatory T Cells (FoxP3 Acts as a Cotranscription Factor with STAT3 in Tumor-Induced Regulatory T Cells (2013) 39(6) (1057–1069), (S1074761313005049), (10.1016/j.immuni.2013.11.005));FoxP3 Acts as a Cotranscription Factor with STAT3 in Tumor-Induced Regulatory T Cells

Immunity

Volumn 39, Issue 6, 2013, Pages 1057-1069

  Hossain, Dewan Md Sakib ^a   Panda, Abir K ^a   Manna, Argha ^a   Mohanty, Suchismita ^a   Bhattacharjee, Pushpak ^a   Bhattacharyya, Sankar ^a   Saha, Taniya ^a   Chakraborty, Sreeparna ^a   Kar, Rajiv K ^a   Das, Tanya ^a   Chatterjee, Subhrangsu ^a   Sa, Gaurisankar ^a  

^a BOSE INSTITUTE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; CYTOKINE; DNA; INTERLEUKIN 10; INTERLEUKIN 2; SHORT HAIRPIN RNA; SMALL INTERFERING RNA; STAT3 PROTEIN; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; BINDING SITE; BREAST CANCER; CD4+ CD25+ T LYMPHOCYTE; CYTOKINE PRODUCTION; DNA PROTEIN COMPLEX; EPIGENETICS; EXON; FLOW CYTOMETRY; GENE DELETION; GENETIC TRANSCRIPTION; GENETIC TRANSDUCTION; HELPER CELL; HUMAN; HUMAN CELL; LENTIVIRINAE; MOLECULAR DOCKING; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SITE DIRECTED MUTAGENESIS; T LYMPHOCYTE SUBPOPULATION; TRANSCRIPTION REGULATION;

EID: 84890177967     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2021.08.008     Document Type: Erratum

References (42)

1. Akdis C.A., Blaser K. Mechanisms of interleukin-10-mediated immune suppression. Immunology 2001, 103:131-136.
2. Bandukwala H.S., Wu Y., Feuerer M., Chen Y., Barboza B., Ghosh S., Stroud J.C., Benoist C., Mathis D., Rao A., Chen L. Structure of a domain-swapped FOXP3 dimer on DNA and its function in regulatory Tcells. Immunity 2011, 34:479-491.
3. Becker S., Groner B., Müller C.W. Three-dimensional structure of the Stat3beta homodimer bound to DNA. Nature 1998, 394:145-151.
4. Benkhart E.M., Siedlar M., Wedel A., Werner T., Ziegler-Heitbrock H.W. Role of Stat3 in lipopolysaccharide-induced IL-10 gene expression. J.Immunol. 2000, 165:1612-1617.
5. Brogdon J.L., Leitenberg D., Bottomly K. The potency of TCR signaling differentially regulates NFATc/p activity and early IL-4 transcription in naive CD4+ Tcells. J.Immunol. 2002, 168:3825-3832.
6. Chakravarti D., Ogryzko V., Kao H.Y., Nash A., Chen H., Nakatani Y., Evans R.M. A viral mechanism for inhibition of p300 and PCAF acetyltransferase activity. Cell 1999, 96:393-403.
7. Chaudhry A., Rudra D., Treuting P., Samstein R.M., Liang Y., Kas A., Rudensky A.Y. CD4+ regulatory Tcells control TH17 responses in a Stat3-dependent manner. Science 2009, 326:986-991.
8. Chen C., Rowell E.A., Thomas R.M., Hancock W.W., Wells A.D. Transcriptional regulation by Foxp3 is associated with direct promoter occupancy and modulation of histone acetylation. J.Biol. Chem. 2006, 281:36828-36834.
9. Cobbold S.P., Castejon R., Adams E., Zelenika D., Graca L., Humm S., Waldmann H. Induction of foxP3+ regulatory Tcells in the periphery of Tcell receptor transgenic mice tolerized to transplants. J.Immunol. 2004, 172:6003-6010.
10. Du J., Huang C., Zhou B., Ziegler S.F. Isoform-specific inhibition of ROR alpha-mediated transcriptional activation by human FOXP3. J.Immunol. 2008, 180:4785-4792.
11. Gavin M.A., Rasmussen J.P., Fontenot J.D., Vasta V., Manganiello V.C., Beavo J.A., Rudensky A.Y. Foxp3-dependent programme of regulatory T-cell differentiation. Nature 2007, 445:771-775.
12. Groux H. Type 1 T-regulatory cells: their role in the control of immune responses. Transplantation 2003, 75(Suppl):8S-12S.
13. Hori S., Nomura T., Sakaguchi S. Control of regulatory Tcell development by the transcription factor Foxp3. Science 2003, 299:1057-1061.
14. Ichiyama K., Yoshida H., Wakabayashi Y., Chinen T., Saeki K., Nakaya M., Takaesu G., Hori S., Yoshimura A., Kobayashi T. Foxp3 inhibits RORgammat-mediated IL-17A mRNA transcription through direct interaction with RORgammat. J.Biol. Chem. 2008, 283:17003-17008.
15. Izcue A., Coombes J.L., Powrie F. Regulatory Tcells suppress systemic and mucosal immune activation to control intestinal inflammation. Immunol. Rev. 2006, 212:256-271.
16. Jaenisch R., Bird A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat. Genet. 2003, 33(Suppl):245-254.
17. Jorgensen W.L., Tirado-Rives J. The OPLS force field for proteins. Energy minimizations for crystals of cyclic peptides and crambin. J.Am. Chem. Soc. 1988, 110:1657-1666.
18. Koch M.A., Tucker-Heard G., Perdue N.R., Killebrew J.R., Urdahl K.B., Campbell D.J. The transcription factor T-bet controls regulatory Tcell homeostasis and function during type 1 inflammation. Nat. Immunol. 2009, 10:595-602.
19. Kortylewski M., Xin H., Kujawski M., Lee H., Liu Y., Harris T., Drake C., Pardoll D., Yu H. Regulation of the IL-23 and IL-12 balance by Stat3 signaling in the tumor microenvironment. Cancer Cell 2009, 15:114-123.
20. Korzus E., Torchia J., Rose D.W., Xu L., Kurokawa R., McInerney E.M., Mullen T.M., Glass C.K., Rosenfeld M.G. Transcription factor-specific requirements for coactivators and their acetyltransferase functions. Science 1998, 279:703-707.
21. Lathers D.M., Achille N.J., Young M.R. Incomplete Th2 skewing of cytokines in plasma of patients with squamous cell carcinoma of the head and neck. Hum. Immunol. 2003, 64:1160-1166.
22. Lee Y.K., Mukasa R., Hatton R.D., Weaver C.T. Developmental plasticity of Th17 and Treg cells. Curr. Opin. Immunol. 2009, 21:274-280.
23. Li B., Samanta A., Song X., Iacono K.T., Bembas K., Tao R., Basu S., Riley J.L., Hancock W.W., Shen Y., et al. FOXP3 interactions with histone acetyltransferase and class II histone deacetylases are required for repression. Proc. Natl. Acad. Sci. USA 2007, 104:4571-4576.
24. Loizou L., Andersen K.G., Betz A.G. Foxp3 interacts with c-Rel to mediate NF-κB repression. PLoS ONE 2011, 6:e18670.
25. Lu L.F., Boldin M.P., Chaudhry A., Lin L.L., Taganov K.D., Hanada T., Yoshimura A., Baltimore D., Rudensky A.Y. Function of miR-146a in controlling Treg cell-mediated regulation of Th1 responses. Cell 2010, 142:914-929.
26. Marson A., Kretschmer K., Frampton G.M., Jacobsen E.S., Polansky J.K., MacIsaac K.D., Levine S.S., Fraenkel E., von Boehmer H., Young R.A. Foxp3 occupancy and regulation of key target genes during T-cell stimulation. Nature 2007, 445:931-935.
27. Maynard C.L., Harrington L.E., Janowski K.M., Oliver J.R., Zindl C.L., Rudensky A.Y., Weaver C.T. Regulatory Tcells expressing interleukin 10 develop from Foxp3+ and Foxp3- precursor cells in the absence of interleukin 10. Nat. Immunol. 2007, 8:931-941.
28. Mintseris J., Pierce B., Wiehe K., Anderson R., Chen R., Weng Z. Integrating statistical pair potentials into protein complex prediction. Proteins 2007, 69:511-520.
29. Motz G.T., Coukos G. Deciphering and reversing tumor immune suppression. Immunity 2013, 39:61-73.
30. Ono M., Yaguchi H., Ohkura N., Kitabayashi I., Nagamura Y., Nomura T., Miyachi Y., Tsukada T., Sakaguchi S. Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1. Nature 2007, 446:685-689.
31. Pan F., Yu H., Dang E.V., Barbi J., Pan X., Grosso J.F., Jinasena D., Sharma S.M., McCadden E.M., Getnet D., et al. Eos mediates Foxp3-dependent gene silencing in CD4+ regulatory Tcells. Science 2009, 325:1142-1146.
32. Pandiyan P., Zheng L., Ishihara S., Reed J., Lenardo M.J. CD4+CD25+Foxp3+ regulatory Tcells induce cytokine deprivation-mediated apoptosis of effector CD4+ Tcells. Nat. Immunol. 2007, 8:1353-1362.
33. Pierce B.G., Hourai Y., Weng Z. Accelerating protein docking in ZDOCK using an advanced 3D convolution library. PLoS ONE 2011, 6:e24657.
34. Platten M., Youssef S., Hur E.M., Ho P.P., Han M.H., Lanz T.V., Phillips L.K., Goldstein M.J., Bhat R., Raine C.S., et al. Blocking angiotensin-converting enzyme induces potent regulatory Tcells and modulates TH1- and TH17-mediated autoimmunity. Proc. Natl. Acad. Sci. USA 2009, 106:14948-14953.
35. Ramsdell F. Foxp3 and natural regulatory Tcells: key to a cell lineage?. Immunity 2003, 19:165-168.
36. Saraiva M., O'Garra A. The regulation of IL-10 production by immune cells. Nat. Rev. Immunol. 2010, 10:170-181.
37. Takeda K., Clausen B.E., Kaisho T., Tsujimura T., Terada N., Förster I., Akira S. Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. Immunity 1999, 10:39-49.
38. Tatsumi T., Kierstead L.S., Ranieri E., Gesualdo L., Schena F.P., Finke J.H., Bukowski R.M., Mueller-Berghaus J., Kirkwood J.M., Kwok W.W., Storkus W.J. Disease-associated bias in T helper type 1 (Th1)/Th2 CD4(+) Tcell responses against MAGE-6 in HLA-DRB10401(+) patients with renal cell carcinoma or melanoma. J.Exp. Med. 2002, 196:619-628.
39. Wang T., Niu G., Kortylewski M., Burdelya L., Shain K., Zhang S., Bhattacharya R., Gabrilovich D., Heller R., Coppola D., et al. Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells. Nat. Med. 2004, 10:48-54.
40. Williams L.M., Rudensky A.Y. Maintenance of the Foxp3-dependent developmental program in mature regulatory Tcells requires continued expression of Foxp3. Nat. Immunol. 2007, 8:277-284.
41. Wu Y., Borde M., Heissmeyer V., Feuerer M., Lapan A.D., Stroud J.C., Bates D.L., Guo L., Han A., Ziegler S.F., et al. FOXP3 controls regulatory Tcell function through cooperation with NFAT. Cell 2006, 126:375-387.
42. Zheng Y., Josefowicz S.Z., Kas A., Chu T.T., Gavin M.A., Rudensky A.Y. Genome-wide analysis of Foxp3 target genes in developing and mature regulatory Tcells. Nature 2007, 445:936-940.